Dosidal · Switzerland

Decitabin Sandoz, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68233 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68233
atc: L01BC08
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-10-19
term: zugelassen
valid_until: 2027-10-18
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01BC08
authorisation_number: 68233
form: PULPI
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 07.16.1.
name: Decitabin Sandoz, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
IVEee5kEf7pKE6p1wUKpVCMnK6Aw97t-0MBIJFHALnIL9EG_ktcjsIj8-JMnVlLOny6rAjqD9nkbCPvwqXk1xg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal